Skip to content
Open access

In-silico Exploration of Drug Leads Targeting Mycobacterial Ag85C

Oct 2026 · bioRxiv · 0 citations · 6 references
Biology

TL;DR

This study aims to identify potential inhibitors of the Ag85C enzyme from Mycobacterium tuberculosis through primary docking, pharmacophore modelling, and ADME/pharmacokinetics analysis, yielding three promising candidates.

Read PDF

Similar papers

Open access Sep 2026

Computational evaluation of novel Schiff base compounds targeting Mycobacterium tuberculosis

Background/Aim Tuberculosis remains a major global health concern and continues to pose significant challenges to global public health. Key enzymes involved in mycobacterial cell wall biosynthesis, including DprE1, InhA, KasA, MmpL3, and LdtMt2, represent attractive therapeutic targets for anti-tubercular drug discover...

Akshata S. Menasinakai, P. Ronad, A. V. Viswanatha Swamy · 0 citations
Open access Sep 2026

In silico Identification of Antiviral Polyphenols from Phoenix dactylifera Targeting SARS-CoV-2 Main Protease

COVID-19, caused by SARS-CoV-2, depends on its main protease (Mpro) for viral replication. This study evaluated the potential of polyphenolic compounds from Phoenix dactylifera as Mpro inhibitors using molecular docking, molecular dynamics (MD) simulations, and ADMET profiling. Three ligands - flavoxanthin, violaxanthi...

G. M. Gholam, R. A. P. Irsal, F. R. Mahendra et al. · 0 citations
Open access Sep 2026

Discovery and Structure–Activity Relationship Optimization of a Novel Rv1625c Agonist Chemotype with Antitubercular Activity

Rv1625c/Cya has emerged as a promising target for the development of treatment-shortening therapies for tuberculosis. Screening of an Enamine compound library identified sBQQ004 as an initial hit, and rapid hit optimization led to compound 1, which was subsequently confirmed as an Rv1625c/Cya agonist. Structure–activit...

Han Xie, Paridhi Sukheja, Kirsten T. Tolentino et al. · 0 citations
Open access Sep 2026

Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole‐Based Hydrazide Derivatives as Potential Anti‐Tuberculosis Agents

Findings highlight the potential of benzisothiazole‐based hydrazide derivatives as promising scaffolds for the development of new antitubercular agents and suggest InhA as a potential molecular target.

V. Sharma, Arun Sharma, Ruchi Poria et al. · 0 citations
Open access 2026

In Silico Design and Assessment of Coumarin Derivatives for Anticancer Activity

Background/Objectives: Cancer remains one of the leading causes of mortality worldwide, demanding the discovery of safer and more effective therapeutic agents. Methods: In this study, a comprehensive coumarin derivative library containing 2,681 compounds was compiled from literature and online chemical databases. After...

A. Pandey, Anuvanshika Yadav, Anupam Tiwari et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.